[HTML][HTML] Current cancer burden in China: epidemiology, etiology, and prevention
Cancer has become the most common cause of death in China. Owing to rapid economic
development, improved livelihood, and shifts in risk factors, cancer epidemiology has …
development, improved livelihood, and shifts in risk factors, cancer epidemiology has …
[HTML][HTML] Overview and countermeasures of cancer burden in China
Cancer is one of the leading causes of human death worldwide. Treatment of cancer
exhausts significant medical resources, and the morbidity and mortality caused by cancer is …
exhausts significant medical resources, and the morbidity and mortality caused by cancer is …
[HTML][HTML] National and subnational trends in cancer burden in China, 2005–20: an analysis of national mortality surveillance data
J Qi, M Li, L Wang, Y Hu, W Liu, Z Long… - The Lancet Public …, 2023 - thelancet.com
Background Cancer has been the leading cause of death since 2010 in China, with
increasing incidence, mortality, and burden. We aimed to assess national and subnational …
increasing incidence, mortality, and burden. We aimed to assess national and subnational …
[HTML][HTML] PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma
X Hu, Y He, Z Han, W Liu, D Liu, X Zhang, L Chen… - Cell death & …, 2022 - nature.com
Effective strategies for hepatocellular carcinoma, which is the second leading cause of death
worldwide, remain limited. A growing body of emerging evidence suggests that ferroptosis …
worldwide, remain limited. A growing body of emerging evidence suggests that ferroptosis …
Adjuvant role of Salvia miltiorrhiza bunge in cancer chemotherapy: A review of its bioactive components, health-promotion effect and mechanisms
J Huang, J Zhang, C Sun, R Yang, M Sheng… - Journal of …, 2024 - Elsevier
Ethnopharmacological relevance Chemotherapy is a common cancer treatment strategy.
However, its effectiveness is constrained by toxicity and adverse effects. The Lamiaceae …
However, its effectiveness is constrained by toxicity and adverse effects. The Lamiaceae …
EGCG alleviates obesity-exacerbated lung cancer progression by STAT1/SLC7A11 pathway and gut microbiota
F Li, S Hao, J Gao, P Jiang - The Journal of Nutritional Biochemistry, 2023 - Elsevier
Leptin is a nutritional cytokine, and it is closely related to the progression of cancer.
However, the detailed effect of leptin in lung cancer remains poorly known. We found leptin …
However, the detailed effect of leptin in lung cancer remains poorly known. We found leptin …
[HTML][HTML] Nanomaterials: small particles show huge possibilities for cancer immunotherapy
Z Chen, Z Yue, K Yang, S Li - Journal of Nanobiotechnology, 2022 - Springer
With the economy's globalization and the population's aging, cancer has become the
leading cause of death in most countries. While imposing a considerable burden on society …
leading cause of death in most countries. While imposing a considerable burden on society …
Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors
China faces a disproportionate cancer burden to the population size and is undergoing a
transition in the cancer spectrum. We extracted data in five aspects of cancer incidence …
transition in the cancer spectrum. We extracted data in five aspects of cancer incidence …
[HTML][HTML] Stomach cancer burden in China: Epidemiology and prevention
In 2020, stomach cancer was the fifth most commonly diagnosed cancer and the fourth
leading cause of cancer-related death worldwide. Due to the relatively huge population …
leading cause of cancer-related death worldwide. Due to the relatively huge population …
[HTML][HTML] Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies
W Wang, L Zhang, Z Sun - Cancer Biology & Medicine, 2022 - ncbi.nlm.nih.gov
Immune checkpoint blockade (ICB) therapy has recently shown promise in treating several
malignancies. However, only a limited number of patients respond to this treatment, partially …
malignancies. However, only a limited number of patients respond to this treatment, partially …